Norway· NO-ID_3F7B9C30-22AA-4352-BC8E-6F67B164F223
Utrogestan
A progesterone product containing progesterone + micronised, registered in Norway by Besins Healthcare Ireland Limited. The same ATC class is registered in 15 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Progesterone is registered in 15 of 19 countries.
Countries holding a registration under ATC G03DA04 (progesterone), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Progesterone · ATC G03DA04
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of progesterone costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.57 in Italy to $1.52 in Switzerland — a ×2.7 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Progesterone · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.52
- IT Italy$0.57
The record
At a glance
FEST (Norway)- Active substance
- Progesterone + Micronised
- Manufacturer
- Besins Healthcare Ireland Limited
- Country
- Norway (NO)
- ATC code
- G03DA04
- ATC class
- Progesterone
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_3F7B9C30-22AA-4352-BC8E-6F67B164F223
- no_varenummer46479715NOK 141
- gtin3701217200326
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
216 interactions on record for progesterone.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Progesterone · interactions on record
216 records
- 2 severe
- 122 moderate
- 1 minor
- 91 info
Most severe, free to view
- EdoxabanB01AF03severe
- VenetoclaxL01XX52severe
- ClotrimazoleA01AB18moderate
- AprepitantA04AD12moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under G03DA04
Progesterone, as other registers publish it.
- CanadaACT PROGESTERONE INJECTIONTEVA CANADA LIMITED
- CzechiaAGOLUTINBB Pharma a.s., Praha
- NorwayAmelgen2care4 ApS
- DenmarkAmelgenOrifarm A/S
- CzechiaAMELGENGedeon Richter Plc., Budapešť
- CzechiaAMELGENGedeon Richter Plc., Budapešť
- CzechiaAMELGENGedeon Richter Plc., Budapešť
- CzechiaAMELGENGedeon Richter Plc., Budapešť
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fc5023e6-547c-456e-bf15-9af72f761e6c GET /v1/drugs/fc5023e6-547c-456e-bf15-9af72f761e6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Vaginalkapsel, myk",
"source": "fest",
"status": "A",
"atc_name": "Progesteron",
"merkevare_id": "ID_3F7B9C30-22AA-4352-BC8E-6F67B164F223",
"name_form_strength": "Utrogestan vag kaps 200 mg",
"prescription_group": "C"
}See everything about progesterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.